Selected research
Industry Research
Drug Microneedle Patches Industry Research Report 2026
Market perspective
The global Drug Microneedle Patches market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drug Microneedle Patches is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drug Microneedle Patches is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug Microneedle Patches include Anodyne Nanotech, CosMED Pharmaceutical, Harro Höfliger, Micron Biomedical, Raphas, VaxessTechnologies, Beijing CAS Microneedle Technology, Guangzhou Novaken Pharmaceutical and Nantong Weizhen Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug Microneedle Patches market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Microneedle Patches Market by Company
Anodyne Nanotech
CosMED Pharmaceutical
Harro Höfliger
Micron Biomedical
Raphas
VaxessTechnologies
Beijing CAS Microneedle Technology
Guangzhou Novaken Pharmaceutical
Nantong Weizhen Pharmaceutical
Shenzhen Qinglan Biotechnology
Wuhan Tianshiwei
WCC Biomedical
Zhuhai Youwe Biotechnology
Drug Microneedle Patches Segment by Type
Dissolving Microneedles
Solid Microneedles
Others
Drug Microneedle Patches Segment by Application
Hospitals
Beauty Institutions
Others
Drug Microneedle Patches Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Microneedle Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Microneedle Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Microneedle Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Microneedle Patches manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Microneedle Patches by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Microneedle Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dissolving Microneedles
- Solid Microneedles
- Others
Applications
- Hospitals
- Beauty Institutions
- Others
Companies covered
- Anodyne Nanotech
- CosMED Pharmaceutical
- Harro Höfliger
- Micron Biomedical
- Raphas
- VaxessTechnologies
- Beijing CAS Microneedle Technology
- Guangzhou Novaken Pharmaceutical
- Nantong Weizhen Pharmaceutical
- Shenzhen Qinglan Biotechnology
- Wuhan Tianshiwei
- WCC Biomedical
- Zhuhai Youwe Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drug Microneedle Patches Market Size (2021-2032)
- 2.2.2 Global Drug Microneedle Patches Sales (2021-2032)
- 2.2.3 Global Drug Microneedle Patches Market Average Price (2021-2032)
- 2.3 Drug Microneedle Patches by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dissolving Microneedles
- 2.3.3 Solid Microneedles
- 2.3.4 Others
- 2.4 Drug Microneedle Patches by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Beauty Institutions
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug Microneedle Patches Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drug Microneedle Patches Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Drug Microneedle Patches Revenue of Manufacturers (2021-2026)
- 3.4 Global Drug Microneedle Patches Average Price by Manufacturers (2021-2026)
- 3.5 Global Drug Microneedle Patches Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drug Microneedle Patches, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drug Microneedle Patches, Product Type & Application
- 3.8 Global Manufacturers of Drug Microneedle Patches, Established Date
- 3.9 Global Drug Microneedle Patches Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Anodyne Nanotech
- 4.1.1 Anodyne Nanotech Company Information
- 4.1.2 Anodyne Nanotech Business Overview
- 4.1.3 Anodyne Nanotech Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Anodyne Nanotech Drug Microneedle Patches Product Portfolio
- 4.1.5 Anodyne Nanotech Recent Developments
- 4.2 CosMED Pharmaceutical
- 4.2.1 CosMED Pharmaceutical Company Information
- 4.2.2 CosMED Pharmaceutical Business Overview
- 4.2.3 CosMED Pharmaceutical Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CosMED Pharmaceutical Drug Microneedle Patches Product Portfolio
- 4.2.5 CosMED Pharmaceutical Recent Developments
- 4.3 Harro Höfliger
- 4.3.1 Harro Höfliger Company Information
- 4.3.2 Harro Höfliger Business Overview
- 4.3.3 Harro Höfliger Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Harro Höfliger Drug Microneedle Patches Product Portfolio
- 4.3.5 Harro Höfliger Recent Developments
- 4.4 Micron Biomedical
- 4.4.1 Micron Biomedical Company Information
- 4.4.2 Micron Biomedical Business Overview
- 4.4.3 Micron Biomedical Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Micron Biomedical Drug Microneedle Patches Product Portfolio
- 4.4.5 Micron Biomedical Recent Developments
- 4.5 Raphas
- 4.5.1 Raphas Company Information
- 4.5.2 Raphas Business Overview
- 4.5.3 Raphas Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Raphas Drug Microneedle Patches Product Portfolio
- 4.5.5 Raphas Recent Developments
- 4.6 VaxessTechnologies
- 4.6.1 VaxessTechnologies Company Information
- 4.6.2 VaxessTechnologies Business Overview
- 4.6.3 VaxessTechnologies Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 VaxessTechnologies Drug Microneedle Patches Product Portfolio
- 4.6.5 VaxessTechnologies Recent Developments
- 4.7 Beijing CAS Microneedle Technology
- 4.7.1 Beijing CAS Microneedle Technology Company Information
- 4.7.2 Beijing CAS Microneedle Technology Business Overview
- 4.7.3 Beijing CAS Microneedle Technology Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing CAS Microneedle Technology Drug Microneedle Patches Product Portfolio
- 4.7.5 Beijing CAS Microneedle Technology Recent Developments
- 4.8 Guangzhou Novaken Pharmaceutical
- 4.8.1 Guangzhou Novaken Pharmaceutical Company Information
- 4.8.2 Guangzhou Novaken Pharmaceutical Business Overview
- 4.8.3 Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Product Portfolio
- 4.8.5 Guangzhou Novaken Pharmaceutical Recent Developments
- 4.9 Nantong Weizhen Pharmaceutical
- 4.9.1 Nantong Weizhen Pharmaceutical Company Information
- 4.9.2 Nantong Weizhen Pharmaceutical Business Overview
- 4.9.3 Nantong Weizhen Pharmaceutical Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nantong Weizhen Pharmaceutical Drug Microneedle Patches Product Portfolio
- 4.9.5 Nantong Weizhen Pharmaceutical Recent Developments
- 4.10 Shenzhen Qinglan Biotechnology
- 4.10.1 Shenzhen Qinglan Biotechnology Company Information
- 4.10.2 Shenzhen Qinglan Biotechnology Business Overview
- 4.10.3 Shenzhen Qinglan Biotechnology Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shenzhen Qinglan Biotechnology Drug Microneedle Patches Product Portfolio
- 4.10.5 Shenzhen Qinglan Biotechnology Recent Developments
- 4.11 Wuhan Tianshiwei
- 4.11.1 Wuhan Tianshiwei Company Information
- 4.11.2 Wuhan Tianshiwei Business Overview
- 4.11.3 Wuhan Tianshiwei Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Wuhan Tianshiwei Drug Microneedle Patches Product Portfolio
- 4.11.5 Wuhan Tianshiwei Recent Developments
- 4.12 WCC Biomedical
- 4.12.1 WCC Biomedical Company Information
- 4.12.2 WCC Biomedical Business Overview
- 4.12.3 WCC Biomedical Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 WCC Biomedical Drug Microneedle Patches Product Portfolio
- 4.12.5 WCC Biomedical Recent Developments
- 4.13 Zhuhai Youwe Biotechnology
- 4.13.1 Zhuhai Youwe Biotechnology Company Information
- 4.13.2 Zhuhai Youwe Biotechnology Business Overview
- 4.13.3 Zhuhai Youwe Biotechnology Drug Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Zhuhai Youwe Biotechnology Drug Microneedle Patches Product Portfolio
- 4.13.5 Zhuhai Youwe Biotechnology Recent Developments
5 Global Drug Microneedle Patches Market Scenario by Region
- 5.1 Global Drug Microneedle Patches Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drug Microneedle Patches Sales by Region: 2021-2032
- 5.2.1 Global Drug Microneedle Patches Sales by Region: 2021-2026
- 5.2.2 Global Drug Microneedle Patches Sales by Region: 2027-2032
- 5.3 Global Drug Microneedle Patches Revenue by Region: 2021-2032
- 5.3.1 Global Drug Microneedle Patches Revenue by Region: 2021-2026
- 5.3.2 Global Drug Microneedle Patches Revenue by Region: 2027-2032
- 5.4 North America Drug Microneedle Patches Market Facts & Figures by Country
- 5.4.1 North America Drug Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drug Microneedle Patches Sales by Country (2021-2032)
- 5.4.3 North America Drug Microneedle Patches Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drug Microneedle Patches Market Facts & Figures by Country
- 5.5.1 Europe Drug Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drug Microneedle Patches Sales by Country (2021-2032)
- 5.5.3 Europe Drug Microneedle Patches Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drug Microneedle Patches Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drug Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drug Microneedle Patches Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drug Microneedle Patches Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drug Microneedle Patches Market Facts & Figures by Country
- 5.7.1 South America Drug Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drug Microneedle Patches Sales by Country (2021-2032)
- 5.7.3 South America Drug Microneedle Patches Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drug Microneedle Patches Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drug Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drug Microneedle Patches Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drug Microneedle Patches Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drug Microneedle Patches Sales by Type (2021-2032)
- 6.1.1 Global Drug Microneedle Patches Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Drug Microneedle Patches Sales Market Share by Type (2021-2032)
- 6.2 Global Drug Microneedle Patches Revenue by Type (2021-2032)
- 6.2.1 Global Drug Microneedle Patches Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drug Microneedle Patches Revenue Market Share by Type (2021-2032)
- 6.3 Global Drug Microneedle Patches Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drug Microneedle Patches Sales by Application (2021-2032)
- 7.1.1 Global Drug Microneedle Patches Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Drug Microneedle Patches Sales Market Share by Application (2021-2032)
- 7.2 Global Drug Microneedle Patches Revenue by Application (2021-2032)
- 7.2.1 Global Drug Microneedle Patches Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drug Microneedle Patches Revenue Market Share by Application (2021-2032)
- 7.3 Global Drug Microneedle Patches Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drug Microneedle Patches Value Chain Analysis
- 8.1.1 Drug Microneedle Patches Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drug Microneedle Patches Production Mode & Process
- 8.2 Drug Microneedle Patches Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drug Microneedle Patches Distributors
- 8.2.3 Drug Microneedle Patches Customers
9 Global Drug Microneedle Patches Analyzing Market Dynamics
- 9.1 Drug Microneedle Patches Industry Trends
- 9.2 Drug Microneedle Patches Industry Drivers
- 9.3 Drug Microneedle Patches Industry Opportunities and Challenges
- 9.4 Drug Microneedle Patches Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst